Cordyceps Sunshine Biotech Holdings Co., Ltd. Quarterly Liabilities and Equity in USD from Q4 2020 to Q4 2023

Taxonomy & unit: us-gaap: USD
Description: Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.
Summary: Cordyceps Sunshine Biotech Holdings Co., Ltd. quarterly Liabilities and Equity history and growth rate from Q4 2020 to Q4 2023.
Cordyceps Sunshine Biotech Holdings Co., Ltd. Liabilities and Equity for the quarter ending December 31, 2023 was $3.42M, a 62.6% increase year-over-year.

Liabilities and Equity, Quarterly (USD)

Liabilities and Equity, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q4 2023	$3.42M	+$1.32M	+62.6%	Dec 31, 2023	20-F	2024-07-05
Q3 2023	$1.8M			Sep 30, 2023	6-K	2023-11-13
Q4 2022	$2.1M	-$1.16M	-35.5%	Dec 31, 2022	20-F	2024-07-05
Q4 2021	$3.26M	+$437K	+15.5%	Dec 31, 2021	20-F	2023-05-15
Q4 2020	$2.83M			Dec 31, 2020	20-F	2023-05-15

* An asterisk sign (*) next to the value indicates that the value is likely invalid.